ThinkingFit: Combined Physical, Cognitive and Social Treatment in Mild Cognitive Impairment (MCI)
ThinkingFit
Piloting a Complex Intervention Involving Physical Exercise, Cognitive Training and Socialising to Delay the Onset of Dementia in Mild Cognitive Impairment
1 other identifier
interventional
128
1 country
1
Brief Summary
Dementia is serious problem and around 700 000 people are affected in the UK alone. Currently there is no cure however early diagnosis and effective treatment offers hope for reducing the impact. Dementia sufferers require care due to physical disability, cognitive deficits, social isolation and emotional symptoms (depression). Delaying the onset of dementia will improve quality of life for patients and reduce the cost of residential care (£42 000 per person per year). People with mild cognitive impairment (MCI) are at high risk of developing dementia. They have impaired cognitive abilities, such as memory, but still manage their everyday activities. Studies show that 8 out of 10 people with MCI will have developed dementia 6 years after diagnosis. Regular physical activities and performing a variety of cognitive activities reduce the risk of dementia and improves abilities and quality of life in healthy people. Therefore a combination of these activities may reduce the risk of developing dementia in MCI. The investigators want to see if they can develop a program which combines these activities in a fun and social way that gets people active and keeps them active. The aims are to improve fitness, cognition and quality of life. The investigators plan to use computers and the internet to help with the activities and to make them available to people who are isolated. Physical activity will involve walking from home, cognitive activities will be computer based games and puzzles and socialising will involve regular varied group-based activities. Participants (128) will be recruited from the UCL Derwent Memory Clinic and will complete a 26 week program. They will then be followed up yearly to monitor their progress. The main outcome of the study is engagement in the activities. The investigators will also measure fitness, cognition, quality of life and conversion to dementia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 17, 2012
CompletedFirst Posted
Study publicly available on registry
May 23, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedApril 28, 2014
April 1, 2014
2.8 years
May 17, 2012
April 25, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Activity Compliance
Number of participants to have completed 50% or more of the programmed activity sessions during the intervention period.
Compliance with programmed activities will be assessed at the end of participation which is expected to be at 24 weeks
Secondary Outcomes (3)
Cardiovascular fitness measure
This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.
Cognitive measures
This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.
Measures of quality of life and everyday activities
This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.
Study Arms (1)
ThinkingFit
EXPERIMENTALInterventions
Combined physical, cognitive and social stimulation activties.
Eligibility Criteria
You may qualify if:
- Patients fulfilling criteria for AMCI \[Petersen et al. 2001b\]:
- i. Memory impairment for age and education ii. No impairment in other cognitive domains iii. Normal social activities iv. Patient is not demented
- For the other subtypes of MCI, cognitive impairment in one or more nonmemory domain
- Sedentary lifestyle with no regular participation in physical exercise defined as two or three times a week for at least 20 minutes duration, or participation in active sport more than once a week, in the previous six months.
- Willing and able to give informed consent.
- Availability and access to safe exercise environments, such as paths or roads with sidewalks for walking or cycling.
- At low risk from serious adverse effects from increased physical activity as indicated by performance on the revised Physical activity readiness questionnaire (PARQ).
You may not qualify if:
- Type 1 (insulin dependent) diabetes mellitus.
- Blood pressure of 160/100 mmHg or more.
- Body weight more than 140% of ideal body weight.
- Musculoskeletal or other medical problems preventing safe participation in regular moderate intensity exercise (65-77% of predicted maximum heart rate). This will include a resting tachycardia (heart rate above 100 bpm) and history of myocardial infarction or unstable angina within the last month.
- Participants taking medications affecting heart rate will need to be on a stable dosing regime for 3 months prior to commencing in order to control for potential spurious results on fitness measures caused by these treatments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr Thomas Dannhauserlead
- University College, Londoncollaborator
Study Sites (1)
North Essex Partnership Foundation NHS Trust
Harlow, Essex, cm20 1qx, United Kingdom
Related Publications (1)
Dannhauser TM, Cleverley M, Whitfield TJ, Fletcher BC, Stevens T, Walker Z. A complex multimodal activity intervention to reduce the risk of dementia in mild cognitive impairment--ThinkingFit: pilot and feasibility study for a randomized controlled trial. BMC Psychiatry. 2014 May 5;14:129. doi: 10.1186/1471-244X-14-129.
PMID: 24886353DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Cleverley
North Essex Partnership Foundation NHS Trust
- STUDY DIRECTOR
Thomas M Dannhauser, PhD
University College London, North Essex Partnership NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Consultant Psychiatrist and Honorary Senior Lecturer in Psychiatry
Study Record Dates
First Submitted
May 17, 2012
First Posted
May 23, 2012
Study Start
January 1, 2010
Primary Completion
November 1, 2012
Study Completion
November 1, 2012
Last Updated
April 28, 2014
Record last verified: 2014-04